Nasdaq
NEUP
Neuphoria Therapeutics Inc.
- Health Care
- Listed 2021
- 1 day
- −1.3%
- 1 month
- +8.6%
- 1 year
- −50.3%
$3.90 · Mkt cap $21.1M
At the 6 Aug 2026 close
Nasdaq
Neuphoria Therapeutics Inc.
$3.90 · Mkt cap $21.1M
At the 6 Aug 2026 close
Neuphoria Therapeutics Inc. trades under the ticker NEUP on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $21.1M. The last closing price was $3.90, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −50.3%, and +8.6% over the past month. Returns are price returns and exclude dividends.
This page exists because NEUP is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.